Claritev (CTEV) Asset Writedowns and Impairment (2022 - 2024)
Claritev (CTEV) recorded quarterly Asset Writedowns and Impairment of $54.5 million in Q4 2024, down 84.92% quarter-over-quarter from $361.6 million in Q3 2024.
Claritev (CTEV) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
Claritev's Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $54.5 million for Q4 2024.
- In Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $54.5 million; the TTM figure through Sep 2025 stood at $54.5 million (down 96.2% YoY), while the FY2024 annual figure was $1.5 billion, changed N/A from the prior year.
- Asset Writedowns and Impairment was $54.5 million for Q4 2024 at Claritev, down from $361.6 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $660.3 million in Q4 2022 to a low of $54.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Claritev | 489.92 Mn | 461.92 Mn | 175.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 54.54 Mn |
| Dec 31, 2024 | 54.54 Mn |
| Sep 30, 2024 | 361.60 Mn |
| Sep 30, 2024 | 361.60 Mn |
| Jun 30, 2024 | 553.70 Mn |
| Jun 30, 2024 | 553.70 Mn |
| Mar 31, 2024 | 519.10 Mn |
| Mar 31, 2024 | 519.10 Mn |
| Dec 31, 2022 | 660.30 Mn |
| Dec 31, 2022 | 660.30 Mn |